139 related articles for article (PubMed ID: 3084469)
21. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
[TBL] [Abstract][Full Text] [Related]
22. Molecular heterogeneity in human beta-galactosidase and neuraminidase deficiency.
Galjaard H; Willemsen R; Hoogeveen AT; Mancini GM; Palmeri S; Verheijen FW; D'Azzo A
Enzyme; 1987; 38(1-4):132-43. PubMed ID: 3126043
[TBL] [Abstract][Full Text] [Related]
23. A microassay for acid beta-galactosidase activity toward asialofetuin.
Mutoh T; Naoi M; Sobue I; Kiuchi K; Nagatsu T
Clin Chim Acta; 1985 Nov; 152(3):307-14. PubMed ID: 2415273
[TBL] [Abstract][Full Text] [Related]
24. Acid beta-galactosidase from human fibroblasts. A microscale purification method monitored by a highly sensitive enzyme assay.
Furuya T; Suzuki Y; Momoi T
J Biochem; 1986 Feb; 99(2):437-43. PubMed ID: 3084462
[TBL] [Abstract][Full Text] [Related]
25. Impaired degradation of keratan sulfate in GM1-gangliosidosis.
Yutaka T; Okada S; Kato T; Yabuuchi H
Clin Chim Acta; 1982 Oct; 125(2):233-40. PubMed ID: 6216030
[No Abstract] [Full Text] [Related]
26. Diagnosis of feline GM1 gangliosidosis by enzyme assay of cultured conjunctival cells.
Nowakowski RW; Thompson JN; Baker HJ
Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):487-90. PubMed ID: 3125124
[TBL] [Abstract][Full Text] [Related]
27. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
[TBL] [Abstract][Full Text] [Related]
28. Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.
Yoshida K; Oshima A; Shimmoto M; Fukuhara Y; Sakuraba H; Yanagisawa N; Suzuki Y
Am J Hum Genet; 1991 Aug; 49(2):435-42. PubMed ID: 1907800
[TBL] [Abstract][Full Text] [Related]
29. Beta-galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells.
Oshima A; Itoh K; Nagao Y; Sakuraba H; Suzuki Y
Hum Genet; 1990 Oct; 85(5):505-8. PubMed ID: 2121639
[TBL] [Abstract][Full Text] [Related]
30. [Generalized GM1 gangliosidosis. Report of a case and review of the literature].
Pérez R; Cuesta JM; Haro de los Monteros N; Hernando Mayor y Montes JC
An Esp Pediatr; 1984 May; 20(8):783-8. PubMed ID: 6433763
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of the enzymically deficient cross reacting material in GM1 gangliosidoses.
Ben-Yoseph Y; Burton BK; Nadler HL
Am J Hum Genet; 1977 Nov; 29(6):575-80. PubMed ID: 412418
[TBL] [Abstract][Full Text] [Related]
32. GM1 gangliosidosis--one case report.
Shi HP; Luo HY; Zhao SM; Qin M; Bao MZ
Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(2):114-5. PubMed ID: 3124093
[No Abstract] [Full Text] [Related]
33. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
[TBL] [Abstract][Full Text] [Related]
34. Dog GM1 gangliosidosis: characterization of the residual liver acid beta-galactosidase.
Rittmann LS; Tennant LL; O'Brien JS
Am J Hum Genet; 1980 Nov; 32(6):880-9. PubMed ID: 6778205
[TBL] [Abstract][Full Text] [Related]
35. [The use of loading tests with labeled GM1-ganglioside for differential diagnosis of GM1-gangliosidosis].
Akhunov VS; Krasnopol'skaia KD; Mirenburg TV
Vopr Med Khim; 1989; 35(5):119-22. PubMed ID: 2515652
[TBL] [Abstract][Full Text] [Related]
36. Enzyme replacement using liposome carriers in feline Gm1 gangliosidosis fibroblasts.
Reynolds GC; Baker HJ; Reynolds RH
Nature; 1978 Oct; 275(5682):754-5. PubMed ID: 100709
[No Abstract] [Full Text] [Related]
37. Type 3 (chronic) GM1 gangliosidosis presenting as infanto-choreo-athetotic dementia, without epilepsy, in three sisters.
Guazzi GC; D'Amore I; Van Hoof F; Fruschelli C; Alessandrini C; Palmeri S; Federico A
Neurology; 1988 Jul; 38(7):1124-7. PubMed ID: 3133574
[TBL] [Abstract][Full Text] [Related]
38. A two-year-old patient with an atypical expression of GM1-beta-galactosidase deficiency: biochemical, immunological, and cell genetic studies.
Reuser AJ; Andria G; de Wit-Verbeek E; Hoogeveen A; del Giudice E; Halley D
Hum Genet; 1979 Jan; 46(1):11-9. PubMed ID: 107114
[TBL] [Abstract][Full Text] [Related]
39. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
Inui K
Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
[TBL] [Abstract][Full Text] [Related]
40. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
Fujibayashi S; Wenger DA
Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
